Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.
2.

Modelling antibiotic and cytotoxic isoquinoline effects in Staphylococcus aureus, Staphylococcus epidermidis and mammalian cells.

Cecil A, Ohlsen K, Menzel T, François P, Schrenzel J, Fischer A, Dörries K, Selle M, Lalk M, Hantzschmann J, Dittrich M, Liang C, Bernhardt J, Ölschläger TA, Bringmann G, Bruhn H, Unger M, Ponte-Sucre A, Lehmann L, Dandekar T.

Int J Med Microbiol. 2015 Jan;305(1):96-109. doi: 10.1016/j.ijmm.2014.11.006. Epub 2014 Nov 27.

PMID:
25500547
3.

Highly selective antiplasmodial naphthylisoquinoline alkaloids from Ancistrocladus tectorius.

Bringmann G, Zhang G, Olschläger T, Stich A, Wu J, Chatterjee M, Brun R.

Phytochemistry. 2013 Jul;91:220-8. doi: 10.1016/j.phytochem.2012.02.017. Epub 2012 Mar 27.

PMID:
22459968
4.

[Urinary tract infections: cystitis, pyelonephritis, urosepsis].

Fünfstück R, Wagenlehner FM, Olschläger T, Naber KG.

Dtsch Med Wochenschr. 2012 Feb;137(5):198-201. doi: 10.1055/s-0031-1292886. Epub 2012 Jan 25. Review. German. No abstract available.

PMID:
22278690
5.

Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host.

Gronbach K, Eberle U, Müller M, Olschläger TA, Dobrindt U, Leithäuser F, Niess JH, Döring G, Reimann J, Autenrieth IB, Frick JS.

Infect Immun. 2010 Jul;78(7):3036-46. doi: 10.1128/IAI.00218-10. Epub 2010 Apr 26.

6.

How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains.

Brzuszkiewicz E, Brüggemann H, Liesegang H, Emmerth M, Olschläger T, Nagy G, Albermann K, Wagner C, Buchrieser C, Emody L, Gottschalk G, Hacker J, Dobrindt U.

Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12879-84. Epub 2006 Aug 15.

7.

A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages.

Karch H, Schubert S, Zhang D, Zhang W, Schmidt H, Olschläger T, Hacker J.

Infect Immun. 1999 Nov;67(11):5994-6001.

8.

Characterization of Escherichia coli strains isolated from environmental water habitats and from stool samples of healthy volunteers.

Mühldorfer I, Blum G, Donohue-Rolfe A, Heier H, Olschläger T, Tschäpe H, Wallner U, Hacker J.

Res Microbiol. 1996 Oct;147(8):625-35.

PMID:
9157489
9.

Regulation of the Shiga-like toxin II operon in Escherichia coli.

Mühldorfer I, Hacker J, Keusch GT, Acheson DW, Tschäpe H, Kane AV, Ritter A, Olschläger T, Donohue-Rolfe A.

Infect Immun. 1996 Feb;64(2):495-502.

10.

Domains of colicin M involved in uptake and activity.

Pilsl H, Glaser C, Gross P, Killmann H, Olschläger T, Braun V.

Mol Gen Genet. 1993 Jul;240(1):103-12.

PMID:
8341256
11.

The biology of colicin M.

Harkness RE, Olschläger T.

FEMS Microbiol Rev. 1991 Jul;8(1):27-41. Review.

PMID:
1931137
12.

Binding of the immunity protein inactivates colicin M.

Olschläger T, Turba A, Braun V.

Mol Microbiol. 1991 May;5(5):1105-11.

PMID:
1956288
15.

Sequence, expression and localization of the immunity protein for colicin B.

Schramm E, Olschläger T, Tröger W, Braun V.

Mol Gen Genet. 1988 Jan;211(1):176-82.

PMID:
2830463
16.

Sequence, expression, and localization of the immunity protein for colicin M.

Olschläger T, Braun V.

J Bacteriol. 1987 Oct;169(10):4765-9.

17.

Primary structure of colicin M, an inhibitor of murein biosynthesis.

Köck J, Olschläger T, Kamp RM, Braun V.

J Bacteriol. 1987 Jul;169(7):3358-61.

18.

Cloning and expression of the activity and immunity genes of colicins B and M on ColBM plasmids.

Olschläger T, Schramm E, Braun V.

Mol Gen Genet. 1984;196(3):482-7.

PMID:
6094976

Supplemental Content

Loading ...
Support Center